β2-microglobulin amyloid

Amyloid

Volumn 7, Issue 1, 2000, Pages 17-18

  Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Amyloidosis; Beta 2 microglobulin; Hemodialysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID; BETA 2 MICROGLOBULIN; HLA ANTIGEN;

AMYLOIDOSIS; ARTICLE; BONE CYST; CARPAL TUNNEL SYNDROME; HEMODIALYSIS; HLA SYSTEM; HUMAN; KIDNEY TRANSPLANTATION; LONG TERM CARE; OSTEOARTHROPATHY; PRIORITY JOURNAL;

AMYLOID; ANIMALS; BETA 2-MICROGLOBULIN; HUMANS;

EID: 0034113089     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120009146818     Document Type: Article

References (6)

1. Warren DJ and Otieno LS (1975). Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 51, 450-452
2. Assenat H, Calemard E, Charta B, Laurent G, Terrat JC and Vanel T (1980). Hemodialyse: syndrome du canal carpien et substance amyloide (letter). Nouvelle Presse Med 9, 1715
3. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS and Schmid K (1985). A new form of amyloid protein associated with hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129, 701-706
4. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K and Kinoshita T (1993). β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92, 1243-1252
5. Hashimoto N, Naiki H and Gejyo F (1999). Modification of β2-microglobulin with D-glucose or 3-deoxyglucosone inhibits Aβ2M amyloid fibril extension in vitro. Amyloid: Int J Exp Clin Invest 6, 256-264
6. Gejyo F, Teramura T, Ei I, Arakawa M, Nakazawa R, Azuma N, Suzuki M, Furuyoshi S, Nankou T, Takata S and Yasuda A (1995). Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for β2-microglobulin on the treatment for dialysis-related amyloidosis. Artif Organs 19, 1222-1226.